At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
The successful candidate will join the drug discovery group at the Mechanisms of Cancer Resistance Thematic Research Center at Bristol-Myers Squibb in Cambridge, MA. The individual will aid in the discovery and advancement of novel cancer therapeutics targeting immune modulators of tumor growth and/or tumor intrinsic biology.
The qualified candidate will be a highly motivated, interactive, and creative individual that possesses the ability to work across a matrixed environment to advance drug discovery programs from target validation to IND enabling activities, and ultimately to Proof of Concept in patients. Experience leading small molecule, drug discovery programs through lead optimization and characterization will be highly valued.
The candidate will lead a group of scientists responsible for developing and executing strategies using a wide range of in vitro and in vivo models. The candidate is expected to work seamlessly with colleagues across BMS Thematic Research Centers and collaborators in medicinal chemistry, MAP/DMPK, preclinical safety, pharmacology, translational research, and early clinical development. He/she will lead efforts to understand biological mechanisms of action, identify biomarkers for target and pathway engagement, understand target engagement requirements for response, potential patient selection hypotheses and combination opportunities in disease relevant models.
For more information and to apply click HERE